ABBV data by YCharts Fresh off its acquisition of Allergan -- which cost the company $63 billion and closed in May -- AbbVie has several things going its way.However, Biogen recently lost a patent lawsuit against Mylan over Tecfidera,Â which means sales of this MS drug could face generic competition soon.